IDH2 and acute myeloid leukemia: Since the main function of IDH2 is to catalyze the metabolic conversion between isocitrate and α-KG [29], we thus used mass spectrometry to quantitatively measure the immediate metabolites of IDH2, including α-KG, isocitrate, and citrate in AML cells with or without IDH2 knockdown.